Skip to main content
. 2008 Jun;24(6):797–804. doi: 10.1089/aid.2007.0246

Table 3.

Individual Subjects with Resistance-Associated Mutations (RAMs) Identified at Enrollment and/or at 6–12 weeks Postpartum in Plasma or PBMC Specimens

 
 
ARV regimens during pregnancy
CD4 and viral load testing
RAMs—plasma specimens
RAMs—PBMC specimens
Subject Deliverya ARV regimenb Starta Stopa Duration (days) Visit (timing)c CD4+cnt/% Viral load (copies/mL) Enrolld 6–12 weeksd Enrolld 6–12 weeksd
1 38.4 None 0.1 13.7 96 Enrl (37.4) 418/40 4,685 NT K70R NT NT
    3TC, NVP, ZDV 13.9 39.3 179 HD (38.6) 846/45          
    None 39.3 48.7 67 6–12 (48.7) 729/34 3,140        
2 38.0 None 0.1 25.7 180 Enrl (32.0) 348/30 646 NT K70R NT K70R
    3TC, NVP, ZDV 25.9 38.9 92 HD (38.1) 503/24 228        
    None 38.9 44.0 37 6–12 (44.0) 446/18 61,115        
3 39.1 None 0.1 23.7 166 Enrl (33.0) 261/51 82 NT K70R K70R NT
    3TC, NVP, ZDV 23.9 39.1 108 HD (40.0) 238/50          
    None 39.1 47.0 56 6–12 (47.0) 156/22          
4 41.0 None 0.1 27.3 191 Enrl (34.0) 554/41 400 NT M184V None None
    3TC, ZDV 27.4 31.0 26 HD (41.3) 516/40 400        
    3TC, NVP, ZDV 31.1 43.0 84 6–12 (47.9) 473/29 11,400        
    3TC, ZDVe 43.1 43.4 3              
    None 43.4 47.9 32              
5 38.3 None 0.1 20.1 141 Enrl (36.0) 430/38 6,760 K70R None NT None
    3TC, ZDV 20.3 35.0 104 HD (38.7) 677/41 508        
    3TC, NVP, ZDV 35.1 41.0 42 6–12 (45.9) 535/36 11,800        
    3TC, ZDVe 41.1 41.4 3              
    None 41.4 45.9 32              
6 40.3 None 0.1 31.3 219 Enrl (34.0) 507/31 478 NT K103N NT None
    ZDV 31.4 32.1 6 HD (40.7) 623/35          
    3TC, NVP, ZDV 32.3 43.1 77 6–12 (49.9) 616/34 16,400        
    None 43.1 49.9 48              
7 37.7 None 0.1 27.0 189 Enrl (36.0) 327/25 3,670 NT K103N K70R None
    ZDV 27.1 37.1 71 HD (38.1) 447/25          
    3TC, NVP, ZDV 37.3 40.0 20 6–12 (43.9) 524/32 4,710        
    3TC, ZDVe 40.1 40.4 3              
    None 40.4 43.9 25              
8 40.0 None 0.1 26.0 182 Enrl (23.0) 858/42 198,000 K70R NT K70R, M461 K70R, D30N
    3TC, NVP, ZDV 26.1 43.0 119 Ante (34.0) 772/59 950        
    NVPe 43.1 43.4 3 HD (40.3) 879/55          
    None 43.4 45.9 18 6–12 (45–9) 684/51 11,300        
9 39.0 None 0.1 25.0 175 Enrl (26.0) 465/35 554 NT M184V K70R M184V
    3TC, NVP, ZDV 25.1 30.1 36 Ante (34.0) 458/39          
    None 30.3 32.0 13 HD (39.3) 721/36          
    3TC, NVP, ZDV 32.0 44.9 91 6–12 (44.9) 709/34 2,010        
10 38.0 None 0.1 20.4 143 Enrl (35.7) 613/41 50 NT K70R NT NT
    3TC, NVP, ZDV 20.6 30.9 73 HD (39.4) 854/45 50        
    3TC, NVP, d4T 31.0 38.1 51 6–12 (44.7) 650/38 11,557        
    NVPe 38.3 38.9 5              
    None 38.9 44.7 42              
11 35.4 None 0.1 23.6 165 Enrl (25.1) 330/30 7,792 NT D67N, K70R, K219Q, M41L, V82A NT NT
    3TC, NFV, ZDV 23.7 35.6 84 Ante (35.1) 207/25          
    None 35.6 43.1 54 HD (35.9) 326/30 106        
            6–12 (43.1) 311/26 21,255        
12 40.1 None 0.1 18.0 126 Enrl (28.0) 462/39 155 M46I None NT NT
    ZDV 18.1 24.0 42 Ante (34.0) 535/44          
    3TC, NFV, ZDV 24.1 40.3 114 HD (40.3) 317/22          
    None 40.3 49.0 62 6–12 (49.0) 448/21 14,213        
13 40.1 None 0.1 22.0 154 Enrl (25.0) 469/NA   NT V179D V179D NT
    3TC, NVP, ZDV 22.1 25.1 22 Ante (34.0) 697/58          
    3TC, ZDV 25.3 25.3 1 HD (40.4) 715/51 60        
    ZDV 25.4 40.6 107 6–12 (47.7) 585/32 3,443        
    None 40.6 47.7 51              
14 37.9 None 0.1 13.7 96 Enrl (36.0) 649/NA 6,167 D30N, K103N, M184V, V108I D30N, K103N, M184V, V108I None D30N, K103N, M184V, V108I, V75I
    3TC, NFV, ZDV 13.9 40.9 190 HD (38.0) 457/NA 11,290        
    None 40.9 48.0 51 6–12 (48.0) 635/40 5,961        
15 39.4 None 0.1 26.7 187 Enrl (31.0) 551/39 227 L210W, M41L, (E44D and V118I) NT L210W, M41L, (E44D and V118I) L210W, M41L, (E44D V118I), D67N
    3TC, NFV, ZDV 26.9 39.4 89 HD (39.7) 896/NA          
    None 39.4 48.0 61 6–12 (48.0) 538/36          
16 38.7 None 0.1 24.6 172 Enrl (30.0) 165/24 5,620 NT M184V None M184V
    3TC, ZDV 24.7 44.3 138 HD (39.0) 167/23 44,000        
    None 44.3 48.0 27 6–12 (48.0) 105/21 75,000        
17 40.7 None 0.1 29.9 209 Enrl (33.0) 806/45   NT M41L NT NT
    3TC, ZDV 30.0 40.9 77 HD (41.0) 398/44          
    None 40.9 49.0 58 6–12 (49.0) 655/36 6,810        
18 37.7 None 0.1 23.9 167 Enrl (33.0) 436/29 5,790 NT M184V None NT
    3TC, ZDV 24.0 43.3 136 HD (38.0) 348/26 14,100        
    None 43.3 50.0 48 6–12 (50.0) 389/24 7,910        
19 39.7 None 0.1 25.9 181 Enrl (19.0) 311/26 2,050 NT M46I NT None
    3TC, NVP, ZDV 26.0 40.0 99 Ante (33.0) 360/30          
    None 40.0 47.7 55 HD (40.0) 402/29 61        
            6–12 (47.7) 445/28 1,001        
20 39.1 None 0.1 30.1 211 Enrl (30.0) 1119/38 1,610 V108I NT NT NT
    3TC, ZDV 30.3 39.7 67 HD (40.0) 1170/43          
    None 39.7 52.0 87 6–12 (52.0) 979/38 1,371        
21 43.1 None 0.1 22.9 160 Enrl (12.0) 336/20 31,967 M46I None NT NT
    3TC, ZDV 23.0 33.3 73 Ante (21.9) 336/21 47,806        
    3TC, NFV, ZDV 33.4 43.4 71 Ante (32.0) 490/31 3,711        
    None 43.4 52.0 61 HD (43.9) 866/37 1,886        
            6–12 (52.0) 407/18 95,623        
22 37.7 None 0.1 12.7 89 Enrl (22.0) 747/37   NT V179D NT NT
    3TC, NFV, ZDV 12.9 37.7 175 Ante (32.7) 736/46          
    None 37.7 46.7 64 HD (38.0) 656/40          
            6–12 (46.7) 806/36 6,460        
23 40.0 None 0.1 28.0 196 Enrl (35.0) 926/33 83 NT NT NT L33F
    3TC, NVP, ZDV 28.1 40.1 85 HD (40.3) 573/36 54,340        
    None 40.1 47.0 49 6–12 (47.0) 501/23 8,908        
24 37.1 None 0.1 19.3 135 Enrl (37.0) 232/30   NT NT K70R K70R
    3TC, NVP, ZDV 19.4 37.1 125 HD (37.3) 240/33          
    None 37.1 44.1 50 6–12 (44.1) 288/34          
25 36.3 None 0.1 18.0 126 Enrl (27.0) 343/25 44,900 NT NT NT K70R
    ZDV 18.1 30.1 85 Ante (34.0) 428/38 597        
    3TC, NVP, ZDV 30.3 36.9 47 HD (37.3) 925/42 400        
    3TC, ZDVe 37.0 37.3 3 6–12 (42.9) 494/25 37,000        
    None 37.3 42.9 40              
26 37.6 None 0.1 26.0 182 Enrl (27.0) 403/31   NT NT K70R K70R
    3TC, NVP, ZDV 26.1 40.0 98 Ante (33.0) 351/36          
    3TC, ZDVe 40.1 40.4 3 HD (37.9) 717/32          
    None 40.4 43.9 25 6–12 (43.9) 490/35 556        
27 38.0 None 0.1 33.6 235 Enrl (38.0) 556/29 2,280 NT NT NT K70R
    3TC, ZDV 33.7 38.1 32 HD (38.3) 597/22 13,500        
    None 38.1 47.1 64 6–12 (47.1) 3100/59 23,700        
28 29.9 None 0.1 28.0 196 Enrl (27.0) 245/21 379,193 NT NT G190A None
    ZDV 28.1 29.9 13 HD (30.6) 441/22 7,651        
    None 29.9 40.0 72 6–12 (40.0) 468/30 175,785        
29 37.7 None 0.1 18.9 132 Enrl (18.0) 196/23 3,524 NT NT M46I None
    3TC, ZDV 19.0 37.9 133 Ante (34.0) 380/24 101        
    None 37.9 45.9 57 HD (38.0) 372/35 162        
            6–12 (45.9) 299/20 3,823        
30 40.7 None 0.1 18.4 129 Enrl (26.0) 301/35 5,900 NT NT K103N, M184V, V108I K103N
    3TC, NFV, ZDV 18.6 33.9 108 Ante (34.3) 373/33 496        
    IDV, TDF, d4T 34.0 42.1 58 HD (40.9) 446/36 418        
    None 42.1 47.3 37 6–12 (47.3) 288/32 28,300        
31 39.1 None 0.1 18.7 131 Enrl (20.0) 440/16 3,400 NT NT NT K70R
    3TC, NFV, ZDV 18.9 39.3 144 Ante (32.0) 292/24          
    None 39.3 45.7 46 HD (39.3) 588/26          
            6–12 (45.7) 398/14 54,900        
32 31.0 None 0.1 21.7 152 Enrl (31.0) 587/33   NT NT NT K103N
    3TC, NFV, ZDV 21.9 31.1 66 HD (31.7) 323/34 4,320        
    None 31.1 42.7 82 6–12 (42.7) 309/26 60,000        
a

Delivery date and start and stop of ARV use during pregnancy are given in weeks of gestation.

b

“None” used to denote periods during pregnancy (through 6–12 week postpartum visit) when no ARVs were received.

c

Visit and timing (in weeks of gestation) corresponding to available CD4+ count, CD4+ percent and viral load (HIV-1 RNA) measures. Visits: Enrl = enrollment; Ante = antepartum visit; HD = hospital discharge; and 6–12 = 6–12 week postpartum visit.

d

NT = sample not tested for resistance; None = no resistance associated mutations were detected. Where resistance associated mutations were detected, the specific codon substitutions are identified.

e

ARVs started after delivery.